Medical News: AAN: Cancer Risk Low with Interferon Beta-1a for MS - in Meeting Coverage, AAN from MedPage Today
Links shared publicly online about this topic.
- 1,238total visits
Medical News: AAN: Cancer Risk Low with Interferon Beta-1a for MS - in Meeting Coverage, AAN from MedPage Today
TORONTO -- Data from controlled clinical trials and postmarketing surveillance indicate that multiple sclerosis patients treated with subcutaneous interferon Beta-1a (Rebif) do not have an increased r
View full resource at medpagetoday.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Cancer, Clinical Trial, Avonex, Rebif
Most Recently Shared on April 15, 2010 at 3:37 pm By:
AAN: Cancer Risk Low with Interferon Beta-1a for MS (CME/CE) TORONTO (MedPage Today) -- Data from controlled clinical t.. http://dld.bz/at6s
Advertisement
